Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Jiri Vorlicek"'
Autor:
Hana Šváchová, Pavel Nemec, L. Kovarova, Zdenek Adam, Miroslav Penka, Ludek Pour, Lucie Burešová, Martina Almáši, Roman Hájek, Tomas Buchler, Jiri Vorlicek
Publikováno v:
Annals of Hematology
Annals of Hematology, Springer Verlag, 2009, 89 (4), pp.385-389. ⟨10.1007/s00277-009-0834-3⟩
Annals of Hematology, Springer Verlag, 2009, 89 (4), pp.385-389. ⟨10.1007/s00277-009-0834-3⟩
International audience; Angiogenesis plays a significant role in the pathogenesis of multiple myeloma (MM). We have measured concentrations of angiogenesis activators, including vascular endothelial growth factor (VEGF), basic fibroblast growth facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dcb8937e6a0978c97664bbcd161e80e
https://doi.org/10.1007/s00277-009-0834-3
https://doi.org/10.1007/s00277-009-0834-3
Autor:
František Jedlička, Ingrid Vášová, Lenka Šmardová, Milan Navrátil, Lubomír Elbl, Barbora Wagnerová, Jiri Vorlicek, Iva Tomášková, Zdenek Kral
Publikováno v:
Leukemia & Lymphoma. 47:843-851
The present study assessed several parameters of cardiopulmonary function in patients, after treatment for aggressive non-Hodgkin's lymphoma and Hodgkin's disease, to determine the influence of these parameters on patient's performance status. One hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89be9483a9b6ad036d441782d4d0fdfb
https://doi.org/10.1080/10428190500402559
https://doi.org/10.1080/10428190500402559
Publikováno v:
Annals of Hematology. 84:681-685
Corticosteroid-resistant graft-versus-host disease (GvHD) is difficult to manage and is associated with high morbidity and mortality. The purpose of our study was to evaluate the safety and efficacy of mycophenolate mofetil (MMF) as the salvage thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47dca12688df71aa88626f0d566d4154
https://doi.org/10.1007/s00277-005-1070-0
https://doi.org/10.1007/s00277-005-1070-0
Autor:
Zdenek Adam, Adam Svobodník, Tomáš Büchler, Marta Krejčí, Jiri Vorlicek, Roman Hájek, Jaroslav Bacovsky, Jiri Minarik, Vlastimil Scudla, Jiri Mayer
Publikováno v:
The Hematology Journal. 5:559-564
In a retrospective study we have sought to determine whether the administration of angiotensin-I-converting enzyme inhibitors (ACEI) influences the outcome of patients with multiple myeloma (MM). Patients with MM who underwent autologous peripheral b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc7be89e4ab161ac857d89ee4953c4d2
https://doi.org/10.1038/sj.thj.6200571
https://doi.org/10.1038/sj.thj.6200571
Autor:
J. Vinklárková, Doubek M, Daniela Zackova, Martin Klabusay, Tomas Buchler, Alexandra Oltová, Jiri Adler, Jiri Mayer, E. Janovská, Jiri Vorlicek, Eva Krahulcová, Karel Indrak, Edgar Faber, Ladislav Dušek, Petr Kuglík, Korístek Z, Miroslav Penka, Roman Hájek, Iveta Mareschová, Ludmila Bourková
Publikováno v:
Medical Oncology. 20:69-76
Interleukin-2 (IL-2) is able to generate nonspecific cytotoxic effectors from hematopoietic precursors. We evaluated the feasibility and efficacy of chronic myeloid leukemia (CML) treatment with autologous hematopoietic stem cell transplantation (HSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44f3c2415d2475b31084855afe38d173
https://doi.org/10.1385/mo:20:1:69
https://doi.org/10.1385/mo:20:1:69
Publikováno v:
Acta Medica Austriaca. 28:38-42
Summary: Bisphosphonates inhibit osteoclastic bone destruction that may be stimulated by myeloma cells. By this way, bisphosphonates carry the potential to lower the number of new pathological fractures, of hypercalcaemic events, and of intensity o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ba60592e41277e63cf0d0c9343f765
https://doi.org/10.1046/j.1563-2571.2001.01009.x
https://doi.org/10.1046/j.1563-2571.2001.01009.x
Autor:
Lucie Burešová, Krivanová A, Tomas Buchler, Zdenek Adam, Lenka Zahradová, Jiri Vorlicek, Roman Hájek, Ludek Pour, Viera Sandecká, Marta Krejčí
Publikováno v:
Clinical Lymphoma and Myeloma. 9:151-153
Varicella-zoster virus (VZV) reactivation is a common complication in patients with multiple myeloma (MM) treated with bortezomib, with an incidence rate of 10%-60%. The aim of our study was to analyze the effect of acyclovir prophylaxis in this pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd2b0ddea544906489489115e03c5a33
https://doi.org/10.3816/clm.2009.n.036
https://doi.org/10.3816/clm.2009.n.036
Publikováno v:
Bone Marrow Transplantation. 23:413-419
We treated 40 patients with poor prognosis lymphomas. Patients with non-Hodgkin's lymphoma (NHL, n = 14) received MINE chemotherapy (mesna, ifosfamide 1330 mg/m2 and etoposide 65 mg/m2 by i.v. infusions on days 1-3, mitoxantrone 8 mg/m2 i.v. on day 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e02d3972584b6ca0e2e9cde2c4b47599
https://doi.org/10.1038/sj.bmt.1701592
https://doi.org/10.1038/sj.bmt.1701592
Autor:
Martina Lengerová, Zdenek Racil, Pavlína Volfová, Jana Lochmanová, Dana Dvorakova, Jiri Mayer, Jitka Berkovcová, Jiri Vorlicek
Publikováno v:
Journal of Clinical Microbiology. 45:1042-1044
Here we report how variability in the human cytomegalovirus genome sequence may seriously affect the outcome of its molecular diagnosis. A real-time quantitative PCR assay targeting the major immediate-early gene failed to detect the viral load in so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a576f4f699bc06c5f36b6b34eba522
https://doi.org/10.1128/jcm.01109-06
https://doi.org/10.1128/jcm.01109-06
Autor:
Petr Kuglík, Dita Mentzlová, Jitka Malčíková, Jiri Vorlicek, Jana Šmardová, Miluše Svitáková, Soňa Bukovská, Viera Kuhrová, Doubek M, J Zacal, V. Linková, Šárka Pospíšilová, Hana Skuhrová Francová, Dana Dvorakova, Yvona Brychtová, Martin Trbušek, Jiří Mayer, J. Kujíčková
Publikováno v:
Leukemia. 20:1159-1161
Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3be71c5f1803bdb7c635b2961aa0c962
https://doi.org/10.1038/sj.leu.2404195
https://doi.org/10.1038/sj.leu.2404195